Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research
ConditionAnxiety Disorder
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged ≥ 18 years old
Diagnosis of anxiety disorder
Able to comprehend the investigational nature of the protocol and provide informed consent
Disqualifiers
Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting
Trial population
Patients with anxiety disorder who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of anxiety disorder patients who decide to enroll in a clinical research
Time frame
3 months2
Rate of anxiety disorder patients who remain in clinical trial to trial completion
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: